Minocycline (Minocycline Hydrochloride) - Side Effects and Adverse Reactions

ADVERSE REACTIONS

Due to oral minocycline’s virtually complete absorption, side effects to the lower bowel, particularly diarrhea, have been infrequent. The following adverse reactions have been observed in patients receiving tetracyclines.

Gastrointestinal: Anorexia, nausea, vomiting, diarrhea, glossitis, dysphagia, enterocolitis, pancreatitis, inflammatory lesions (with monilial overgrowth) in the anogenital region, and increases in liver enzymes have been reported. Rarely, hepatitis and liver failure have been reported. These reactions have been caused by both the oral and parenteral administration of tetracyclines. Rare instances of esophagitis and esophageal ulcerations have been reported in patients taking the tetracycline-class antibiotics in capsule and tablet form. Most of these patients took the medication immediately before going to bed (see DOSAGE AND ADMINISTRATION ).

Skin: Maculopapular and erythematous rashes. Exfoliative dermatitis has been reported but is uncommon. Fixed drug eruptions have been rarely reported. Lesions occurring on the glans penis have caused balanitis. Erythema multiforme and rarely Stevens-Johnson syndrome have been reported. Photosensitivity is discussed above (see WARNINGS). Pigmentation of the skin and mucous membranes has been reported.

Renal toxicity: Elevations in BUN have been reported and are apparently dose related (see WARNINGS). Acute renal failure has been rarely reported and, in most cases, has been reversible.

Hypersensitivity reactions: Urticaria, angioneurotic edema, polyarthralgia, anaphylaxis, anaphylactoid purpura, pericarditis, exacerbation of systemic lupus erythematosus and rarely pulmonary infiltrates with eosinophilia have been reported. A lupus-like syndrome and serum sickness-like reactions have also been reported.

Blood: Hemolytic anemia, thrombocytopenia, neutropenia, and eosinophilia have been reported.

Central nervous system: Bulging fontanels in infants and benign intracranial hypertension (pseudotumor cerebri) in adults (see PRECAUTIONS-General) have been reported. Headache has also been reported.

Other: When given over prolonged periods, tetracyclines have been reported to produce brownblack microscopic discoloration of the thyroid glands. Very rare cases of abnormal thyroid function have been reported.

Tooth discoloration in pediatric patients less than 8 years of age (see WARNINGS) and also, rarely, in adults have been reported.

Tinnitus and decreased hearing has been rarely reported in patients on minocycline hydrochloride.

REPORTS OF SUSPECTED MINOCYCLINE SIDE EFFECTS / ADVERSE REACTIONS

Possible Minocycline side effects / adverse reactions in 72 year old female

Reported by a physician from Japan on 2012-06-11

Patient: 72 year old female weighing 57.0 kg (125.4 pounds)

Reactions: Persecutory Delusion, Pneumonia, Restlessness, Abnormal Behaviour, Delirium

Adverse event resulted in: hospitalization

Suspect drug(s):
Lyrica
    Dosage: 75 mg, 2x/day
    Administration route: Oral
    Indication: Post Herpetic Neuralgia
    Start date: 2010-07-16
    End date: 2010-07-19

Lyrica
    Dosage: 150 mg, 2x/day
    Administration route: Oral
    Start date: 2010-07-20
    End date: 2010-07-26

Lyrica
    Dosage: 300 mg, 2x/day
    Administration route: Oral
    Start date: 2010-08-03
    End date: 2010-08-10

Amitriptyline HCL
    Dosage: 25 mg, 4x/day
    Administration route: Oral
    Indication: Post Herpetic Neuralgia
    Start date: 2010-05-17
    End date: 2010-05-31

Amitriptyline HCL
    Dosage: 25 mg, 4x/day
    Administration route: Oral
    Start date: 2010-07-19
    End date: 2010-07-27

Amitriptyline HCL
    Dosage: 25 mg, 2x/day
    Administration route: Oral
    Start date: 2010-07-27
    End date: 2010-08-03

Ampicillin Sodium/sulbactam Sodium
    Dosage: 1 df, 2x/day
    Indication: Bronchiolitis
    Start date: 2010-08-10
    End date: 2010-08-11

Lyrica
    Dosage: 225 mg, 2x/day
    Administration route: Oral
    Start date: 2010-07-27
    End date: 2010-08-02

Amitriptyline HCL
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    Start date: 2010-08-03
    End date: 2010-08-10

Amitriptyline HCL
    Dosage: 50 mg, 4x/day
    Administration route: Oral
    Start date: 2010-05-31
    End date: 2010-07-19

Methylprednisolone Sodium Succinate
    Dosage: 250 mg, 1x/day
    Indication: Interstitial Lung Disease
    Start date: 2010-08-10
    End date: 2010-08-11

Minocycline
    Dosage: 1 df, 2x/day
    Indication: Bronchiolitis
    Start date: 2010-08-10
    End date: 2010-08-11

Other drugs received by patient: Famotidine